Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GLP1R | P43220 | 8/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16245210 | 0.92 | DNM1 (0.61) | DNM1NOD1SIRT2GLP1RLPAR3 | |
| SCHEMBL16247362 | 0.92 | KMT2A (0.62) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL7605823 | 0.92 | KMT2A (0.62) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL3691278 | 0.92 | KMT2A (0.62) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL16247361 | 0.92 | KMT2A (0.62) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL21842545 | 0.89 | KMT2A (0.62) | DNM1KMT2ANOD1POLB | |
| SCHEMBL19308453 | 0.89 | KMT2A (0.53) | DNM1KMT2ANOD1SIRT2POLB | |
| SCHEMBL16244978 | 0.86 | KMT2A (0.55) | KMT2ANOD1POLBGLP1RLPAR3 | |
| SCHEMBL13870513 | 0.84 | KMT2A (0.52) | DNM1KMT2ANOD1SIRT2POLB | |
| SCHEMBL12848289 | 0.84 | KMT2A (0.52) | DNM1KMT2ANOD1SIRT2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2813488-A1 | AMPHOTERIC ION-TYPE BASIC AMINO ACID DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2014-12-17 | — | — | EP | claimed |
| US-20140348767-A1 | AMPHOTERIC ION-TYPE BASIC AMINO ACID DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2014-11-27 | — | — | US | claimed |
| EP-2813488-B1 | AMPHOTERIC ION-TYPE BASIC AMINO ACID DERIVATIVE | AJINOMOTO KK (JP) | 2018-05-16 | — | — | EP | disclosed |
| US-9750676-B2 | Basic amino acid derivative that demonstrates a gelling ability in a water system | AJINOMOTO CO., INC. (JP) | 2017-09-05 | — | — | US | disclosed |
| EP-2813488-A1 | AMPHOTERIC ION-TYPE BASIC AMINO ACID DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2014-12-17 | — | — | EP | disclosed |
| US-20140348767-A1 | AMPHOTERIC ION-TYPE BASIC AMINO ACID DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2014-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140348767-A1 | AMPHOTERIC ION-TYPE BASIC AMINO ACID DERIVATIVE | SLC7A1, SLC1A5, BCAT1 | DNM1 2309/4885KMT2A 1448/4885NOD1 1803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.